Press Releases

Search Press Releases
  
Subscribe for Email Alerts
4/17/2019
5:01 PM ET
Press Release

St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine

4/17/2019

Licensing partnership for vector between St. Jude and Mustang Bio announced in Summer, 2018

This Phase 1/2 trial in newly diagnosed infants with XSCID continues to enroll at St. Jude, UCSF...

 Continue Reading
4/9/2019
8:30 AM ET
Press Release

Mustang Bio to Present at the World Orphan Drug Congress USA 2019

4/9/2019

NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
4/1/2019
9:00 AM ET
Press Release

Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance

4/1/2019

NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
3/18/2019
7:30 AM ET
Earnings Release

Mustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate Highlights

3/18/2019

NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
3/13/2019
8:30 AM ET
Press Release

Mustang Bio to Present at Oppenheimer’s 29th Annual Healthcare Conference

3/13/2019

NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen recepto...

 Continue Reading
Displaying 1 to 5 (of 54 releases)